InvestorsHub Logo
Followers 466
Posts 26934
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Monday, 04/21/2008 4:12:44 PM

Monday, April 21, 2008 4:12:44 PM

Post# of 185
Vertex Pharmaceuticals Reviews Clinical Advancements and Reports First Quarter 2008 Financial Results
Monday April 21, 4:01 pm ET
--Telaprevir data in HCV patients who failed current therapies to be presented at EASL--
--Pharmacokinetic analyses in HCV patients show potential for twice-daily dosing of telaprevir--
--VX-770 for cystic fibrosis to advance based on positive results reported in March 2008--


CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today reported consolidated financial results for the quarter ended March 31, 2008.
http://biz.yahoo.com/bw/080421/20080421006287.html?.v=1


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VRTX News